Free Trial

Chemed (CHE) Competitors

Chemed logo
$561.47 -9.75 (-1.71%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$561.32 -0.15 (-0.03%)
As of 05/22/2025 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHE vs. LH, DGX, DVA, CRVL, AMED, MD, AMN, CCRN, OPCH, and BTSG

Should you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Option Care Health (OPCH), and BrightSpring Health Services (BTSG).

Chemed vs.

Chemed (NYSE:CHE) and Laboratory Co. of America (NYSE:LH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

Chemed currently has a consensus price target of $674.00, indicating a potential upside of 20.04%. Laboratory Co. of America has a consensus price target of $270.62, indicating a potential upside of 11.91%. Given Chemed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Chemed is more favorable than Laboratory Co. of America.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87

In the previous week, Chemed had 4 more articles in the media than Laboratory Co. of America. MarketBeat recorded 23 mentions for Chemed and 19 mentions for Laboratory Co. of America. Laboratory Co. of America's average media sentiment score of 1.45 beat Chemed's score of 1.12 indicating that Laboratory Co. of America is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemed
13 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Laboratory Co. of America
16 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Laboratory Co. of America has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemed$2.49B3.30$272.51M$20.5327.35
Laboratory Co. of America$13.18B1.54$746M$8.6527.96

Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemed12.69% 27.86% 19.12%
Laboratory Co. of America 5.73%15.29%7.01%

Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.4%. Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.2%. Chemed pays out 9.7% of its earnings in the form of a dividend. Laboratory Co. of America pays out 33.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years.

95.8% of Chemed shares are held by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are held by institutional investors. 3.3% of Chemed shares are held by company insiders. Comparatively, 0.8% of Laboratory Co. of America shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Chemed has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500.

Laboratory Co. of America received 293 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 63.89% of users gave Laboratory Co. of America an outperform vote while only 63.57% of users gave Chemed an outperform vote.

CompanyUnderperformOutperform
ChemedOutperform Votes
335
63.57%
Underperform Votes
192
36.43%
Laboratory Co. of AmericaOutperform Votes
628
63.89%
Underperform Votes
355
36.11%

Summary

Chemed beats Laboratory Co. of America on 12 of the 22 factors compared between the two stocks.

Get Chemed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHE vs. The Competition

MetricChemedHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$8.21B$3.16B$5.33B$19.30B
Dividend Yield0.34%0.34%5.21%3.83%
P/E Ratio28.3729.4826.7134.53
Price / Sales3.301.13386.0834.83
Price / Cash22.4017.2938.2517.51
Price / Book7.633.596.774.69
Net Income$272.51M-$57.02M$3.23B$1.02B
7 Day Performance-3.11%-3.66%0.48%-2.43%
1 Month Performance-4.39%15.03%9.10%6.27%
1 Year Performance1.20%26.93%18.56%5.78%

Chemed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHE
Chemed
4.7032 of 5 stars
$561.47
-1.7%
$674.00
+20.0%
+0.6%$8.21B$2.49B28.3714,200Positive News
Dividend Announcement
Insider Trade
LH
Laboratory Co. of America
4.7378 of 5 stars
$250.89
+2.1%
$270.62
+7.9%
+20.2%$21.00B$13.18B28.4575,500Positive News
DGX
Quest Diagnostics
4.8399 of 5 stars
$175.93
-0.6%
$185.73
+5.6%
+19.5%$19.64B$10.16B22.8849,000News Coverage
Positive News
Analyst Revision
DVA
DaVita
4.0018 of 5 stars
$144.29
+0.4%
$166.33
+15.3%
+2.8%$11.09B$12.82B13.4370,000Positive News
Analyst Forecast
CRVL
CorVel
1.0188 of 5 stars
$114.08
+1.4%
N/A+22.7%$5.86B$871.31M67.114,230News Coverage
Positive News
Earnings Report
Upcoming Earnings
AMED
Amedisys
2.8195 of 5 stars
$95.42
+0.1%
$100.75
+5.6%
-3.3%$3.13B$2.37B37.8720,000Positive News
MD
Pediatrix Medical Group
1.3512 of 5 stars
$14.34
-1.3%
$16.67
+16.2%
+85.6%$1.23B$1.98B-11.957,850
AMN
AMN Healthcare Services
4.5299 of 5 stars
$22.67
+3.0%
$38.67
+70.6%
-62.0%$865.75M$2.85B-5.894,230Positive News
CCRN
Cross Country Healthcare
3.898 of 5 stars
$13.92
-0.6%
$18.41
+32.2%
-7.1%$456.34M$1.26B-278.342,700Positive News
OPCH
Option Care Health
4.2152 of 5 stars
$31.86
+0.1%
$35.50
+11.4%
+10.3%$5.22B$5.19B26.775,600Positive News
BTSG
BrightSpring Health Services
1.6401 of 5 stars
$22.35
-2.1%
$22.89
+2.4%
+99.7%$3.89B$11.86B-85.9635,000Positive News
High Trading Volume

Related Companies and Tools


This page (NYSE:CHE) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners